Tetrahydrobiopterin Effects on Cognitive Function in Alzheimer's Disease: Biochemical, Molecular and Cognitive Analysis
Study of Memory Loss in Patients with Alzheimers Disease or Mild Cognitive Impairment (MCI)
Sponsor: NIH
Enrolling: Male and Female Patients
IRB Number: AAAT6311
Contact: Ashley Canizares: 646-774-6232 / amc2429@cumc.columbia.edu
Additional Study Information: This research study aims to obtain a greater understanding of the causes of cognitive decline in Alzheimer's disease. We are currently enrolling male and female participants (ages 55 years and older) with Alzheimer's disease, mild cognitive impairment, or healthy controls. Enrolled participants with undergo a small blood draw (about 8 teaspoons) at our clinic and a brief interview about their health status with our research assistant. This research study will involve a single visit for a total of 2.5 hours (some assessments may also be performed remotely), and you will be reimbursed for your travel/transportation and $50 for your participation.
Catherine Clelland, PhD
Do You Qualify?
Are you (or your loved one) at least 55 years old? Yes No
Have you (or your loved one) been diagnosed with Alzheimers Disease or Mild Cognitive Impairment (MCI)? Yes No
You may be eligible for this study

Place Holder

For more information, please contact:
Ashley Canizares